News

High volatility creates opportunities for options sellers. Here’s how one space ETF may fit a cash-secured put strategy.

(Bloomberg) -- US consumers ramped up spending in May across a broad range of retailers, signaling households powered ahead despite higher gasoline prices.Most Read from BloombergRead the 14-Point Draft Memorandum Between the US and IranModi Warns of ‘Shortage of Trust’ Ahead of Trump MeetingIran’s Deputy Foreign Minister Confirms Deal Reached With USNetanyahu Pays a Political Price for Trump’s Iran DealUS Set to Offer Iran Broad Financial Gains in Peace DealThe value of retail purchases rose 0.

June 17 (Reuters) - The main U.S. stock indexes opened higher on Wednesday, as chip stocks rebounded ahead of the first interest rate decision under new Federal Reserve Chair Kevin Warsh.

Technology company Genspark.ai said on Wednesday it had raised $100 million in its extended funding round ‌that valued it at $2.6 billion, underscoring strong investor appetite ‌for AI companies developing workplace productivity tools. The round was backed by existing investors ​including Sozo Ventures, Korea Mirae Asset and UpHonest Capital. The latest investment brings the Palo Alto, California-based company's total Series B financing to $485 million.

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.1% and the actively trad

(Bloomberg) -- It was 180 degrees off the hot trade on Wall Street. Most Read from BloombergRead the 14-Point Draft Memorandum Between the US and IranModi Warns of ‘Shortage of Trust’ Ahead of Trump MeetingIran’s Deputy Foreign Minister Confirms Deal Reached With USNetanyahu Pays a Political Price for Trump’s Iran DealUS Set to Offer Iran Broad Financial Gains in Peace DealSnub Nvidia Corp., the soaring king of artificial intelligence chips. Embrace Adobe Inc., a sinking casualty of AI disruptio

Gold edged lower early Wednesday as the dollar rose after a report showed U.S. retail sales rose mor

Investing.com - U.S. stock futures were broadly steady on Wednesday as investors geared up for a key Federal Reserve interest rate decision and monitored reports on the details of a preliminary Middle East peace agreement.

Treasury yields tick higher ahead of the first interest rate decision under Fed Chairman Kevin Warsh. Rates are expected to remain unchanged. Investors are curious about how Warsh will change the central bank's communications with the public and its forward guidance.

Jabil Inc. (NYSE:JBL) delivered third-quarter fiscal 2026 results ahead of Wall Street expectations, driven by continued strength in artificial intelligence infrastructure and improving performance across several end markets.

June 17 (Reuters) - The wealth division of Morningstar has teamed up with Apollo Global Management, Franklin Templeton and J.P.

Stock Market Today: The Dow Jones index wavered Wednesday ahead of the Fed's decision and Fed Chair Warsh's comments. SpaceX stock rallied.

Investing.com -- Snap Inc. (NYSE:SNAP) shares suffered a brutal 9.6% drubbing Tuesday, marking its worst single-day collapse since March, after CEO Evan Spiegel asked investors to buy into a future where consumers willingly strap a thick, chunky, $2,195 computer to their faces. Spiegel debuted "SPECS"—the company’s first standalone augmented reality glasses—at the Augmented World Expo in California, framing them as the post-smartphone "computer of the future." Wall Street, however, looked at the

What a time it’s been for nLIGHT. In the past six months alone, the company’s stock price has increased by a massive 93.7%, reaching $67.13 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Applied Materials, Inc. (AMAT) shares jump over 7,700% since 1997’s first institutional outlier signal.

(Updates with economic data, recent oil price movement, world markets' overview and corporate stock

Shares of Western Digital Corporation (WDC) gain 11,294% since Big Money first bought big in 1994.

(Bloomberg) -- The Trump phone is finally here — sort of — and it bears little resemblance to the original pitch.Most Read from BloombergRead the 14-Point Draft Memorandum Between the US and IranIran’s Deputy Foreign Minister Confirms Deal Reached With USModi Warns of ‘Shortage of Trust’ Ahead of Trump MeetingNetanyahu Pays a Political Price for Trump’s Iran DealUS Set to Offer Iran Broad Financial Gains in Peace DealFirst introduced a year ago at Trump Tower by President Donald Trump’s eldest s

Jabil (JBL) delivered earnings and revenue surprises of +1.28% and +1.39%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

Ollie's continues to post earnings beats and sales growth, but the stock has lagged other discount retailers despite a bullish analyst outlook.

Netflix shares are sliding as investors eye acquisition deal letdowns and slowing growth.

The market has the most to lose if the central bank raises interest rates. Its rally is powered by tech and AI, making it risky, risky, risky.

Micron Technology stock was back on the rise early Wednesday as the memory-chip maker looks to resume its relentless rally. Micron was leading the rebound in premarket trading, rising 3.5%, the second-best performer in the Only Intel was climbing more ahead of the open. When there’s nothing happening Micron stock tends to gain.

Investing.com -- Jabil Inc. (NYSE: JBL) reported third-quarter fiscal 2026 results that exceeded analyst expectations, though shares fell 2.5% following the announcement.

The top 10 US stocks now have a combined market cap of $25.3 trillion.

Jabil raised its 2026 profit forecast on Wednesday, as the electronic-component maker ‌looks to capitalize on AI-led demand for ‌data centers. A surge in data-center infrastructure spending, driven by strong ​demand for AI computing power, has benefited companies such as Jabil. "AI infrastructure demand remains extremely strong," said CEO Mike Dastoor, adding the company continued to ‌see better-than-expected performance ⁠particularly in its automotive and connected living segment that had earlier been under ⁠pressure.

US stocks look set for a cautious start on Wednesday as investors await the first Federal Reserve interest rate decision under new chair Kevin Warsh, with the focus less on the immediate policy outcome and more on the route forward. Futures point to a flat open for the Dow Jones and S&P...

How other blockbuster IPOs performed after the hype

By Susanna Twidale LONDON, June 17 (Reuters) - A coalition backed by Big Tech companies for carbon removal technology, said on Wednesday it would inject an additional $915 million into the sector, and

<body><p>STORY: Big pharma is receiving pushback from European capitals on drug pricing.&nbsp;</p><p>So they’re turning to a playbook that brought them success in the UK.</p><p>Making threats to pull investment plans to pressure policymakers.&nbsp;</p><p>The industry notched a win when the British government agreed to increase medicine spending as part of a broader deal to avoid U.S.-imposed tariffs.&nbsp;</p><p>The latest nation to face pressure is Germany, which has been debating legislation to tighten spending on medicines.&nbsp;</p><p>A Reuters European Pharma correspondent Maggie Fick said pressure in the last week has ramped up.&nbsp;</p><p>"The CEO of Pfizer wrote a letter to the German chancellor warning that their future investments in the country may be at risk over these proposed changes to pricing laws."</p><p>Meanwhile, AstraZeneca warned that it may not launch new medicines in Germany if these changes go ahead.</p><p>Earlier in June, Eli Lilly announced it would halve a planned $2.7 billion investment, also citing the proposed legislation.&nbsp;</p><p>This bid to cap costs has centered Germany in a broader tussle between drugmakers and European governments that began several months ago.</p><p>That tension has been sharpened by the impact on Europe of U.S. President Donald Trump's pricing push.</p><p>This aims to tie prescription medicine prices in the lucrative U.S. market to ​lower prices elsewhere, including in Europe.</p><p>Major drugmakers have struck deals with the White House to lower drug costs in exchange for tariff exemptions, adding to pressure for increasing prices elsewhere.</p></body>